SCHEMBL5506774

SCHEMBL5506774

N#CC1(NC(=O)C(CS(=O)(=O)CC2CC2)N[C@H](c2ccc(F)cc2)C(F)(F)F)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSS P25774 17/20 1.00
CTSL P07711 15/20 1.00
CTSB P07858 14/20 1.00
CTSK P43235 10/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2818563 1.00 CTSS (1.00) CTSSCTSLCTSBCTSK
SCHEMBL1273010 0.96 CTSS (0.93) CTSSCTSLCTSBCTSK
SCHEMBL1271557 0.96 CTSS (0.93) CTSSCTSLCTSBCTSK
SCHEMBL1273011 0.96 CTSS (0.93) CTSSCTSLCTSBCTSK
SCHEMBL1272813 0.94 CTSS (0.88) CTSSCTSLCTSBCTSK
SCHEMBL14324339 0.94 CTSS (0.88) CTSSCTSLCTSBCTSK
SCHEMBL1272500 0.94 CTSS (0.88) CTSSCTSLCTSBCTSK
SCHEMBL2395979 0.93 CTSS (0.87) CTSSCTSLCTSBCTSK
SCHEMBL2395980 0.93 CTSS (0.87) CTSSCTSLCTSBCTSK
SCHEMBL1271692 0.92 CTSS (0.85) CTSSCTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797032-A1 POLYMORPHS OF THE CYSTEINE PROTEASE INHIBITOR N-(1-CYANOCYCLOPROPYL)-3-CYCLOPROPYLMETHANESULFONYL-2(R)-[2,2,2-TRIFLUORO-1(S)-(4-FLUOROPHENYL)ETHYLAMINO]PROPIONAMIDE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-06-20 EP disclosed
WO-2006034006-A1 POLYMORPHS OF THE CYSTEINE PROTEASE INHIBITOR N- (1-CYANOCYCLOPROPYL)-3-CYCLOPROPYLMETHANSULFONYL-2 (R) - (2,2,2-TRIFLUORO-1 (S) - (4-FLUOROPHENYL) ETHYLAMINO) PROPIONAMIDE SCHERING AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed